Miravo Healthcare

122 articles about Miravo Healthcare

• Miravo Healthcare Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference

  9/7/2021

  Nuvo Pharmaceuticals Inc. (TSX:MRV) (OTCQX:MRVFF) d/b/a Miravo Healthcare today announced it will be featured as a presenting company at the H.C. Wainwright 23rd Annual Global Investment Conference.  The conference is being held as a virtual conference on September 13-15, 2021.

• Miravo Healthcare Announces Receipt of Health Canada Notice of Compliance for the Pediatric Use of Blexten

  8/12/2021

  Nuvo Pharmaceuticals Inc. today announced Health Canada has issued a Notice of Compliance (NOC) in relation to the Company's Supplement to New Drug Submission for the pediatric use of Blexten. 

• Miravo Healthcare Announces Second Quarter 2021 Results

  8/9/2021

  Nuvo Pharmaceuticals Inc. dba Miravo to Host Conference Call/Audio Webcast August 9th at 11:00 a.m. ET

• Miravo HealthcareTM Ireland Enters into Suvexx License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea

  7/29/2021

   Nuvo Pharmaceuticals Inc. (TSX: NRI) (OTCQX: NRIFF) d/b/a Miravo Healthcare ("Miravo" or the "Company"), today announced that its wholly owned subsidiary, Nuvo Pharmaceuticals (Ireland) DAC trading as Miravo Healthcare ("Miravo Ireland"), has entered into an exclusive license and supply agreement (the "License Agreement") with SK Chemicals Co., Ltd. ("SK Chemicals").

• Miravo Healthcare™ Announces Second Quarter 2021 Results Release Date and Conference Call Details

  7/26/2021

  Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare, a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, announced it expects to release its second quarter 2021 financial results before markets open on Monday, August 9, 2021.

• Miravo Healthcare to Present at Access to Giving Virtual Investor Conference

  7/8/2021

  Nuvo Pharmaceuticals ® Inc. has been invited to present at the Access to Giving Virtual Investor Conference, which is being held virtually on July 13-15th, 2021.

• Miravo Healthcare to Present at Summer Solstice - Best Ideas from the Buy Side

  5/27/2021

  - Tuesday, June 1 st – 3:30 p.m. ET - Nuvo Pharmaceuticals ® Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, has been invited to present at the Summer Solstice

• Miravo Healthcare™ Announces Appointment of Mary Ritchie to its Board of Directors

  5/19/2021

  Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare, a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, announced the appointment of Mary Ritchie to its Board of Directors.

• Miravo Healthcare™ Announces Director Election Results of its Annual Meeting of Shareholders

  5/17/2021

  Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, announced that at its 2021 Virtual Annual Meeting of Shareholders held on May 17, 2021, all nominees listed in the management proxy circular dated April 9, 2021 were elected as directors of the Company.

• Miravo Healthcare Announces First Quarter 2021 Results

  5/17/2021

  Q1 2021 Adjusted Total Revenue - $14.5 million - -   Q1 2021 Adjusted EBITDA - $4.4 million - -   Blexten Canadian Prescriptions Increased 22% Year-Over-Year - -   Cambia Canadian Prescriptions Increased 9% Year-Over-Year - Miravo to Hold Virtual Annual Meeting May 17th at 9:00 a.m. ET

• Miravo Healthcare to Present at Q2 Virtual Investor Summit

  5/11/2021

  Nuvo Pharmaceuticals ® Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced Jesse Ledger , Miravo's President & Chief Executive Officer will be presenting at the Q2 Virtual Investor Summit. 

• Miravo Healthcare Announces First Quarter 2021 Results Release Date and Virtual Annual Meeting of Shareholders

  5/3/2021

   Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its first quarter 2021 financial results before markets open on Monday, May 17, 2021 .  

• Miravo Healthcare™ Files Final Base Shelf Prospectus

  4/21/2021

  Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, announced that it has filed and obtained a receipt for a final base shelf prospectus with the securities regulatory authorities in each of the provinces of Canada.

• Miravo Healthcare(TM) to Present at the Planet MicroCap Showcase: VIRTUAL on Thursday, April 22, 2021 at 10:00 a.m. EST

  4/12/2021

  Nuvo Pharmaceuticals today announced that it will be presenting at the Planet MicroCap Showcase:

• Miravo Healthcare to Present at Upcoming Investor Conferences

  4/9/2021

  • Bloom Burton & Co. Healthcare Investor Conference - April 21 st at 10:00 a.m. EST • • Planet MicroCap Showcase - April 22 nd at 10:00 a.m. EST •

• Miravo Healthcare™ Acknowledged In The Globe and Mail's Second-Annual Women Lead Here Benchmark of Executive Gender Diversity

  3/26/2021

  Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare, a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, announced it has earned a spot on the 2021 Report on Business Women Lead Here list, an annual editorial benchmark to identify best-in-class executive gender diversity in corporate Canada.

• Miravo Healthcare™ to Present at Q1 Virtual Investor Summit

  3/11/2021

  Nuvo Pharmaceuticals® Inc. d/b/a Miravo Healthcare, a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, announced Jesse Ledger, Miravo's President & Chief Executive Officer and Kelly Demerino, Miravo's Interim Chief Financial Officer will be presenting at the Q1 Virtual Investor Summit.

• Miravo Healthcare to present at the Q1 Virtual Investor Summit

  3/11/2021

  Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare™ today announced that Jesse Ledger, President & Chief Financial Officer, will be attending the Q1 Virtual Investor Summit.      Event    Q1 Investor Summit           Date   March 23-25th, 2021       Presentation        March 24th @ 3:30PM ET      

• Miravo Healthcare Announces 2020 and Fourth Quarter Results

  3/8/2021

  Fiscal Year 2020 Adjusted Total Revenue - $71.0 million - -   Fiscal Year 2020 Adjusted EBITDA - $28.4 million - -  Blexten Canadian Prescriptions Increased 35% Year-Over-Year - -   Cambia Canadian Prescriptions Increased 17% Year-Over-Year - Miravo to Host Conference Call/Audio Webcast March 8th at 11:00 a.m. ET

• Miravo Healthcare Files Preliminary Base Shelf Prospectus

  3/8/2021

  Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare ("Miravo" or "the Company") a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced that it has filed a preliminary base shelf prospectus with the securities regulatory authorities in each of the provinces of Canada (the "Prospectus").